Kenneth Pienta

Director of Strategy and Innovation, Brady Urological Institute · Johns Hopkins University School of Medicine

Credentials: · · · ·

History

SPORE in Prostate Cancer
National Cancer Institute · P50
Project lead · $1.1M · Johns Hopkins University
2024–2029
The Biology of Prostate Cancer Skeletal Metastases
National Cancer Institute · P01
Project lead · $4.6M · University of Michigan at Ann Arbor
2004–2026
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry
National Cancer Institute · U01
Contact PI · $5.8M · Johns Hopkins University
2015–2023
The Johns Hopkins Physical Sciences Oncology Center
National Cancer Institute · U54
PI · $8M · Johns Hopkins University
2016–2022

Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
Principal investigator · Terminated · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2019–2020
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2017–2022
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
Principal investigator · Completed · Phase 2, Phase 3
Progenics Pharmaceuticals, Inc.
2016–2018
Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer
Principal investigator · Terminated · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2016–2017